American Biosecurity Initiative

Biopharmaceutical capacity is national security infrastructure. Advancing American strength and trusted allied networks against predatory statecraft.

[American Biosecurity Initiative @ambiosecurity]

China's share of global drug development went from 8% to over 30% in a decade. That is a deliberate state strategy.

Walls and tariffs will not reverse it. America wins by out-innovating. Through strength.

New from ABI's Jennifer Crook in @RCDefense:
https://t.co/gIZv5c8NpO

[American Biosecurity Initiative @ambiosecurity]

American medicine is squeezed from two sides. Predatory statecraft abroad. Policy failure at home. The fix is domestic capacity and trusted allied networks. See how the squeeze works in our interactive threat map: https://t.co/Lkw6CMporK

[American Biosecurity Initiative @ambiosecurity]

Securing America's medicine supply means hard tradeoffs. Protectionism can weaken the base it claims to defend. Our policy simulation lets you test the choices and watch capacity rise or fall. See for yourself!

https://t.co/5tjihIRZbY

[American Biosecurity Initiative @ambiosecurity]

The ability to discover, develop, and make our own medicine is national security infrastructure. That capacity is under pressure from abroad and weakening from policy failure at home. We are building the coalition to defend it. https://t.co/YePkdrAinw